These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27400272)

  • 1. High-dose atorvastatin is associated with lower IGF-1 levels in patients with type 1 diabetes.
    Bergen K; Brismar K; Tehrani S
    Growth Horm IGF Res; 2016 Aug; 29():78-82. PubMed ID: 27400272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes.
    Tehrani S; Mobarrez F; Lins PE; Adamson U; Wallén HN; Jörneskog G
    Diab Vasc Dis Res; 2013 Nov; 10(6):483-8. PubMed ID: 23823849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin microvascular reactivity correlates to clinical microangiopathy in type 1 diabetes: A pilot study.
    Tehrani S; Bergen K; Azizi L; Jörneskog G
    Diab Vasc Dis Res; 2020; 17(3):1479164120928303. PubMed ID: 32538145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IGFBP-1 and its protective role in the pathogenesis of microangiopathy in type 1 diabetes mellitus].
    Krsek M; Prázný M; Skrha J; Justová V; Lacinová Z
    Cas Lek Cesk; 2001 Apr; 140(8):234-7. PubMed ID: 11392040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes.
    Khan F; Elhadd TA; Greene SA; Belch JJ
    Diabetes Care; 2000 Feb; 23(2):215-20. PubMed ID: 10868834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microvascular reactivity in type 2 diabetes mellitus and its relation to IGF-I and its binding proteins].
    Krsek M; Prázný M; Skrha J; Justová V; Lacinová Z; Haas T
    Vnitr Lek; 2003 Jul; 49(7):535-40. PubMed ID: 12931435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin administration is associated with dose-related changes in IGF bioavailability.
    Narayanan RP; Gittins M; Siddals KW; Oliver RL; Hudson JE; White A; Durrington P; Davies RR; Rutter MK; Gibson JM
    Eur J Endocrinol; 2013 Apr; 168(4):543-8. PubMed ID: 23333902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
    Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin combined with ticagrelor prevent ischemia-reperfusion induced vascular endothelial dysfunction in healthy young males - A randomized, placebo-controlled, double-blinded study.
    Weisshaar S; Litschauer B; Kerbel T; Wolzt M
    Int J Cardiol; 2018 Mar; 255():1-7. PubMed ID: 29288055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
    Caballero AE; Arora S; Saouaf R; Lim SC; Smakowski P; Park JY; King GL; LoGerfo FW; Horton ES; Veves A
    Diabetes; 1999 Sep; 48(9):1856-62. PubMed ID: 10480619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes.
    Economides PA; Caselli A; Tiani E; Khaodhiar L; Horton ES; Veves A
    J Clin Endocrinol Metab; 2004 Feb; 89(2):740-7. PubMed ID: 14764790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of aspirin and various iontophoresis solution vehicles on skin microvascular reactivity.
    Abou-Elenin K; Xydakis A; Hamdy O; Economides PA; Horton ES; Veves A
    Microvasc Res; 2002 Jan; 63(1):91-5. PubMed ID: 11749076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes.
    Beer S; Feihl F; Ruiz J; Juhan-Vague I; Aillaud MF; Wetzel SG; Liaudet L; Gaillard RC; Waeber B
    Vasc Health Risk Manag; 2008; 4(6):1449-58. PubMed ID: 19337558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
    Saukkonen T; Amin R; Williams RM; Fox C; Yuen KC; White MA; Umpleby AM; Acerini CL; Dunger DB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
    Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA
    Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserved endothelial-dependent and endothelial-independent skin vasodilator responses in relatives of type 1 diabetes patients.
    Rossi M; Matteucci E; Gaddeo C; Giampietro O; Santoro G
    Microvasc Res; 2009 Sep; 78(2):253-5. PubMed ID: 19409398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired skin microcirculation in paediatric patients with type 1 diabetes mellitus.
    Heimhalt-El Hamriti M; Schreiver C; Noerenberg A; Scheffler J; Jacoby U; Haffner D; Fischer DC
    Cardiovasc Diabetol; 2013 Aug; 12():115. PubMed ID: 23937662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.